Protocol Ledger

NCT05781217 · Phase III · RECRUITING

Short Versus Long-term Androgen Deprivation Therapy With Salvage Radiotherapy in Prostate Cancer. URONCOR 0624

Interventional Phase III clinical trial protocol NCT05781217 sponsored by Instituto de Investigación en Oncología Radioterápica - Fundación Española de Oncología Radioterápic in Oncology and Hematology, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2023-03-14 Enrollment: 534 participants (ESTIMATED) Federal Source: clinicaltrials.gov/study/NCT05781217
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)534 participants (ESTIMATED)
Disclosed U.S. Hospital Campuses vs Median (6 sites)3 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT05781217
Protocol FieldVerified Registry Value
NCT IdentifierNCT05781217
Consolidated Lead SponsorInstituto de Investigación en Oncología Radioterápica - Fundación Española de Oncología Radioterápic
Therapeutic Condition CohortOncology and Hematology
Clinical Trial PhasePhase III
Overall Recruitment StatusRECRUITING
Registered Enrollment534 participants (ESTIMATED)
Registered Start Date2023-03-14
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Canonical Hospital Campuses Listed on NCT05781217
Hospital Research SiteLocationSite Profile
Hospital Universitario Vall d'HebronBarcelona, SpainOpen Hospital Dossier ->
Hospital Clinic de BarcelonaBarcelona, SpainOpen Hospital Dossier ->
Hospital de La Santa Creu I Sant PauBarcelona, SpainOpen Hospital Dossier ->

Search related sites and sponsors in the Interactive Directory, explore Oncology and Hematology Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI